Clinical and experimental cardiovascular monitoring

About the group: 

The Clinical and Experimental Cardiovascular Monitoring research group aims to bridge the gap between cutting-edge technology and cardiovascular physiology by integrating novel concepts into clinical applications. Our focus involves the development and validation of innovative technologies for cardiovascular monitoring. We delve into exploring cardiovascular responses concerning novel therapies and minimally invasive surgical techniques.

Our interdisciplinary team comprises experts in anesthesiology, cardiology, and heart surgery. Additionally, we collaborate with technologists specializing in signal processing, data analysis, and sensor development.


The landscape of cardiovascular therapies is rapidly evolving, encompassing minimally invasive surgical procedures, image-guided interventions, and the utilization of mechanical cardiac and circulatory support devices. While these methods aim for minimal invasiveness, they can carry a considerable procedural risk. For instance, the treatment of severe aortic stenosis through Transcatheter Aortic Valve Implantation (TAVI) represents an alternative to open-heart surgery. Conversely, implanting a mechanical heart pump involves a highly invasive procedure that demands meticulous patient and pump monitoring to detect potentially life-threatening complications. Both scenarios necessitate accurate and dependable assessment of cardiovascular status, albeit requiring different approaches owing to their varying levels of invasiveness.

Within this framework, our primary goal is to enhance hemodynamic monitoring for patients in the operating theater and intensive care unit settings. We actively develop, refine, and evaluate novel monitoring techniques. Leveraging state-of-the-art machine learning and artificial intelligence, our aim is to identify severe complications swiftly and optimize the management of cardiovascular instability.

Currently, the Clinical and Experimental Cardiovascular Monitoring research group is engaged in conducting experimental in-vitro and in-vivo studies focused on medical sensor technology. Additionally, we are executing prospective study protocols to evaluate the effects of heart valve interventions and hemodynamic effects during surgery and ablation for colorectal liver metastasis.

We have collaborations with the Department of Medical Technology at OUS, the Oslo Bioimpedance Group, and the Institute of Physics at the University of Oslo.

Page visits: 2220